Stock Research for ALNY

ALNY

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ALNY Stock Chart & Research Data

The ALNY chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ALNY chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ALNY Due diligence Resources & Stock Charts

The ALNY stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ALNY Detailed Price Forecast - CNN Money CNN View ALNY Detailed Summary - Google Finance
Yahoo View ALNY Detailed Summary - Yahoo! Finance Zacks View ALNY Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ALNY Trends & Analysis - Trade-Ideas Barrons View ALNY Major Holders - Barrons
NASDAQ View ALNY Call Transcripts - NASDAQ Seeking View ALNY Breaking News & Analysis - Seeking Alpha
Spotlight View ALNY Annual Report - CompanySpotlight.com OTC Report View ALNY OTC Short Report - OTCShortReport.com
TradeKing View ALNY Fundamentals - TradeKing Charts View ALNY SEC Filings - Bar Chart
WSJ View Historical Prices for ALNY - The WSJ Morningstar View Performance/Total Return for ALNY - Morningstar
MarketWatch View the Analyst Estimates for ALNY - MarketWatch CNBC View the Earnings History for ALNY - CNBC
StockMarketWatch View the ALNY Earnings - StockMarketWatch MacroAxis View ALNY Buy or Sell Recommendations - MacroAxis
Bullish View the ALNY Bullish Patterns - American Bulls Short Pains View ALNY Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ALNY Stock Mentions - StockTwits PennyStocks View ALNY Stock Mentions - PennyStockTweets
Twitter View ALNY Stock Mentions - Twitter Invest Hub View ALNY Investment Forum News - Investor Hub
Yahoo View ALNY Stock Mentions - Yahoo! Message Board Seeking Alpha View ALNY Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ALNY - SECform4.com Insider Cow View Insider Transactions for ALNY - Insider Cow
CNBC View ALNY Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ALNY - OTC Markets
Yahoo View Insider Transactions for ALNY - Yahoo! Finance NASDAQ View Institutional Holdings for ALNY - NASDAQ


Stock Charts

FinViz View ALNY Stock Insight & Charts - FinViz.com StockCharts View ALNY Investment Charts - StockCharts.com
BarChart View ALNY Stock Overview & Charts - BarChart Trading View View ALNY User Generated Charts - Trading View




Latest Financial News for ALNY


Alnylam to Webcast Conference Call Discussing First Quarter 2024 Financial Results
Posted on Thursday April 18, 2024

CAMBRIDGE, Mass., April 18, 2024--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the first quarter ending March 31, 2024 on Thursday, May 2, 2024, before the U.S. financial markets open.


Why Alnylam Pharmaceuticals (ALNY) Stock Might be a Great Pick
Posted on Monday April 08, 2024

Alnylam Pharmaceuticals (ALNY) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.


Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard of Care Antihypertensives in Patients with Inadequately Controlled Hypertension
Posted on Sunday April 07, 2024

CAMBRIDGE, Mass., April 07, 2024--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced positive results from the KARDIA-2 Phase 2 study evaluating the efficacy and safety of a single subcutaneous dose of zilebesiran when added to one of three standard of care antihypertensives including a thiazide-like diuretic (indapamide), calcium channel blocker (amlodipine) or angiotensin receptor blocker (olmesartan). Zilebesiran is an investigational RNAi the


Those who invested in Alnylam Pharmaceuticals (NASDAQ:ALNY) five years ago are up 63%
Posted on Friday March 29, 2024

It hasn't been the best quarter for Alnylam Pharmaceuticals, Inc. ( NASDAQ:ALNY ) shareholders, since the share price...


Stock Market & Investing Books

Enter a stock symbol to view the stock details.